Locations:
Search
Research indicates strong rationale for expanding trial eligibility criteria
Fine-tuning radiation for recurrent cancers
A well-prepared team meets the distinctive needs of patients at hereditary high risk
Early interventions, improved screening access and tailored support services can help patients navigate cancer care
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A newer modality for select patients has shown positive outcomes to date
Dedicated investigators and clinicians bring expertise in drug development and flexible study design
Why urologic oncologists favor the technique for select patients
Retrospective study aims to better stratify risk of disease recurrence
Majority of 1,000 patients seen in 2022 discharged home
Clinical trial strategy was developed through research on a gene associated with treatment-resistant prostate cancer
Advertisement
Advertisement